View of METABOLIC AND CARDIOVASCULAR RISKS OF SECOND-GENERATION ANTIPSYCHOTICS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF WEIGHT GAIN, DYSLIPIDEMIA, HYPERGLYCEMIA, AND QTC PROLONGATION IN ADULTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER COMPARING OLANZAPINE, RISPERID | Frontier in Medical and Health Research

Frontier in Medical & Health Research

← METABOLIC AND CARDIOVASCULAR RISKS OF SECOND-GENERATION ANTIPSYCHOTICS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF WEIGHT GAIN, DYSLIPIDEMIA, HYPERGLYCEMIA, AND QTC PROLONGATION IN ADULTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER COMPARING OLANZAPINE, RISPERID